TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
FRA:NKB2 (USA)   Ordinary Shares
€ 47.4 -1.2 (-2.47%) Jul 17
19.18
P/B:
14.40
Market Cap:
€ 7.38B ($ 8.44B)
Enterprise V:
€ 7.59B ($ 8.68B)
Volume:
144.00
Avg Vol (2M):
457.00
Trade In:

TG Therapeutics Inc (FRA:NKB2) Dividend

TG Therapeutics Inc (FRA:NKB2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:NKB2 Dividend

Does TG Therapeutics Inc (FRA:NKB2) pay a dividend?

TG Therapeutics Inc (FRA:NKB2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't TG Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. TG Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -2% over the past 3 years.

What are dividend-paying alternatives to TG Therapeutics Inc?

For dividend-paying alternatives in TG Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.